Headlines 2022

Highlights of the year

Building research and innovation Another new building project which took major strides forward this year was our new research facility, currently known as the Paterson redevelopment project, which is now being built at The Christie to replace the fire-damaged Paterson building. The new centre will be a

Care closer to home As our patient numbers continue to grow, providing

care closer to home is becoming ever more

Education and collaboration This year saw the continued growth of our School of Oncology with our team delivering high-quality education and training to students, staff, and the national/international cancer workforce. International arm continues to make progress, offering expertise and education to other cancer centres across the globe, this year working with colleagues in Nigeria supporting them over the next decade to develop their clinical and technical expertise. chemotherapy closer to and in patients’ homes, which has been particularly important as part of our drive to keep people safe during the pandemic. Alongside the School of Oncology, our Christie important and this year we were delighted when our plans for a new Christie cancer centre in Macclesfield came to fruition. During 2021/22, we have also seen the further development of our services to provide

Looking ahead Without a doubt, the strength of our underlying patient-centred culture, highly motivated and compassionate staff, oncology expertise and organisational culture will ensure that we can respond in an agile and effective way to any new demands placed upon us as we continue to learn to live with COVID-19. As we look ahead we know that there will be further challenges to face, in particular the need to respond to an increase in demand for our services from patients as a continued after-effect of the pandemic. We are determined to continue to put patients at the heart of everything we do and do everything possible to provide the best possible treatment and care in the years ahead. We remain focussed on innovation and improvement to ensure that all of our services are truly world-class. Prior to the COVID-19 pandemic, our research and innovation team was already operating more than 650 clinical trials at any one time and the facility was one of the biggest cancer clinical trials centres in Europe. Through our National Institute for Health Research (NIHR) Manchester Clinical Research Facility at The Christie, staff and patients benefit from a large, dedicated clinical research environment where patients can participate in complex and early phase clinical trials. Research teams have continued to achieve the recruitment of the first patients to a number of UK, European and global clinical trials meaning that The Christie patients have had unique access to many pioneering therapies. purpose-built biomedical cancer research facility bringing together three powerhouses of innovation – The Christie, The University of Manchester and Cancer Research UK. Construction work is on track on the new facility which will become home to several hundred scientists, doctors, nurses and support staff who will be at the heart of our ambition to lead the world in clinical trial recruitment, supporting the development of new and kinder cancer therapies.

Charitable support Much of our research work is funded through donations and our charity has continued to support the work of the Trust through its fundraising activities and delivers projects, equipment and improvements that are over and above what the NHS funds. Fortunately, as restrictions were eased in the latter part of the year, some of our events began to be reinstated. We remain incredibly grateful to those who have been able to support us throughout the year, albeit in a way that is different to normal. The charity has over 50,000 supporters who helped raise £13.2m this year.

07